首页 | 本学科首页   官方微博 | 高级检索  
     


Mitotic entry: The interplay between Cdk1, Plk1 and Bora
Authors:Alfonso Parrilla  Luca Cirillo  Yann Thomas  Monica Gotta  Anna Santamaria
Affiliation:1. Cell Cycle and Cancer Laboratory, Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR) – Universitat Autònoma de Barcelona (UAB), Barcelona, Spain;2. Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland;3. Jacques Monod Institute, UMR7592, Paris-Diderot University, Centre National de la Recherche Scientifique, Paris, France;4. Swiss National Centre for Competence in Research Program Chemical Biology, Geneva, Switzerland
Abstract:Polo-like kinase 1 (Plk1) is an important mitotic kinase that is crucial for entry into mitosis after recovery from DNA damage-induced cell cycle arrest. Plk1 activation is promoted by the conserved protein Bora (SPAT-1 in C. elegans), which stimulates the phosphorylation of a conserved residue in the activation loop by the Aurora A kinase. In a recent article published in Cell Reports, we show that the master mitotic kinase Cdk1 contributes to Plk1 activation through SPAT-1/Bora phosphorylation. We identified 3 conserved Sp/Tp residues that are located in the N-terminal, most conserved part, of SPAT-1/Bora. Phosphorylation of these sites by Cdk1 is essential for Plk1 function in mitotic entry in C. elegans embryos and during DNA damage checkpoint recovery in mammalian cells. Here, using an untargeted Förster Resonance Energy Transfer (FRET) biosensor to monitor Plk1 activation, we provide additional experimental evidence supporting the importance of these phosphorylation sites for Plk1 activation and subsequent mitotic entry after DNA damage. We also briefly discuss the mechanism of Plk1 activation and the potential role of Bora phosphorylation by Cdk1 in this process. As Plk1 is overexpressed in cancer cells and this correlates with poor prognosis, understanding how Bora contributes to Plk1 activation is paramount for the development of innovative therapeutical approaches.
Keywords:Bora  Plk1 activation  Cdk1  FRET
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号